Menu
Back to Journals » Hepatic Medicine: Evidence and Research » Volume 7
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (188)
- Volume 16, 2024 (3)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 7, 2015
Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil
Fabrício-Silva GM, Poschetzky BS, Perez RM, Santos RC, Cavalini LT, Porto LC
Hepatic Medicine: Evidence and Research 2015, 7:71-79
Published Date: 2 November 2015
Interferon-free combination therapies for the treatment of hepatitis C: current insights
Holmes JA, Thompson AJ
Hepatic Medicine: Evidence and Research 2015, 7:51-70
Published Date: 2 November 2015
Management options in decompensated cirrhosis
Shah NL, Banaei YP, Hojnowski KL, Cornella SL
Hepatic Medicine: Evidence and Research 2015, 7:43-50
Published Date: 15 July 2015
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
Roggeri DP, Roggeri A, Rossi E, Cinconze E, Gasbarrini A, Monici Preti P, De Rosa M
Hepatic Medicine: Evidence and Research 2015, 7:37-42
Published Date: 13 July 2015
Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease
Kawanaka M, Nishino K, Oka T, Urata N, Nakamura J, Suehiro M, Kawamoto H, Chiba Y, Yamada G
Hepatic Medicine: Evidence and Research 2015, 7:29-35
Published Date: 3 June 2015
Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M
Hepatic Medicine: Evidence and Research 2015, 7:21-27
Published Date: 19 May 2015
Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?
Janardhan SV, Reau NS
Hepatic Medicine: Evidence and Research 2015, 7:11-20
Published Date: 16 April 2015
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility
Ferrín G, Aguilar-Melero P, Rodríguez-Perálvarez M, Montero-Álvarez JL, de la Mata M
Hepatic Medicine: Evidence and Research 2015, 7:1-10
Published Date: 13 April 2015